izpis_h1_title_alt

Predicting drug release rate of implantable matrices and better understanding of the underlying mechanisms through experimental design and artificial neural network-based modelling
ID Benkő, Ernő (Author), ID German Ilić, Ilija (Author), ID Kristó, Katalin (Author), ID Regdon, Géza (Author), ID Csóka, Ildikó (Author), ID Pintye-Hódi, Klára (Author), ID Srčič, Stanko (Author), ID Sovány, Tamás (Author)

.pdfPDF - Presentation file, Download (3,15 MB)
MD5: 3F29228395A6E5068F5B1B2F31BE2596
URLURL - Source URL, Visit https://www.mdpi.com/1999-4923/14/2/228 This link opens in a new window

Abstract
There is a growing interest in implantable drug delivery systems (DDS) in pharmaceutical science. The aim of the present study is to investigate whether it is possible to customize drug release from implantable DDSs through drug–carrier interactions. Therefore, a series of chemically similar active ingredients (APIs) was mixed with different matrix-forming materials and was then compressed directly. Compression and dissolution interactions were examined by FT-IR spectroscopy. Regarding the effect of the interactions on drug release kinetics, a custom-made dissolution device designed for implantable systems was used. The data obtained were used to construct models based on artificial neural networks (ANNs) to predict drug dissolution. FT-IR studies confirmed the presence of H-bond-based solid-state interactions that intensified during dissolution. These results confirmed our hypothesis that interactions could significantly affect both the release rate and the amount of the released drug. The efficiencies of the kinetic parameter-based and point-to-point ANN models were also compared, where the results showed that the point-to-point models better handled predictive inaccuracies and provided better overall predictive efficiency.

Language:English
Keywords:drug–excipient interaction, polymers, non-degradable polymers, matrix tablet, controlled release, design of experiments, artificial neural networks
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:16 str.
Numbering:Vol. 14, iss. 2, art. 228
PID:20.500.12556/RUL-137104 This link opens in a new window
UDC:678.7:615
ISSN on article:1999-4923
DOI:10.3390/pharmaceutics14020228 This link opens in a new window
COBISS.SI-ID:94193411 This link opens in a new window
Publication date in RUL:01.06.2022
Views:445
Downloads:95
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Pharmaceutics
Shortened title:Pharmaceutics
Publisher:MDPI
ISSN:1999-4923
COBISS.SI-ID:517949977 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.02.2022

Secondary language

Language:Slovenian
Keywords:interakcija med zdravili, interakcija med pomožnimi snovmi, nerazgradljivost, matrične tablete, nadzorovano sproščanje, načrtovanje eksperimentov, umetne nevronske mreže, zdravila, polimeri

Projects

Funder:Other - Other funder or multiple funders
Funding programme:CEEPUS Mobility
Project number:CIII-RS-1113-01-1718-M-113871

Funder:Other - Other funder or multiple funders
Funding programme:Hungary, Ministry of Innovation and Technology, National Research, Development, and Innovation Fund
Project number:TKP2021-EGA-32

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back